person reading Mr. Paul R. Edick's salary history.

Historical salary details - Mr. Paul R. Edick, Chairman of the Board and Chief Executive Officer, Xeris Biopharma Holdings Inc

Mr. Paul R. Edick is the Chairman of the Board and Chief Executive Officer of Xeris Biopharma Holdings Inc.

Mr. Paul R. Edick

Chairman of the Board and Chief Executive Officer

-
Gross Remuneration
  • Current Company

    Xeris Biopharma Holdings Inc
YEAR COMPANY POSITION SALARY INCREMENT
2024 Xeris Biopharma Holdings Inc Chairman of the Board and Chief Executive Officer - -
2022 Xeris Biopharma Holdings Inc Chairman of the Board and Chief Executive Officer - -
2021 Xeris Biopharma Holdings Inc Chairman of the Board and Chief Executive Officer - -
2020 Milestone Pharmaceuticals Inc Independent Director 118.2 K -71.4 %
2020 Xeris Biopharma Holdings Inc Chairman of the Board and Chief Executive Officer - -
2019 Milestone Pharmaceuticals Inc Chairperson of the Board 412.7 K -
2019 Iterum Therapeutics Plc - 38.3 K -72.3 %
2019 Iterum Therapeutics Plc Chairman of the Board - -
2019 Xeris Biopharma Holdings Inc Chairman of the Board, President and Chief Executi - -
2018 Iterum Therapeutics Plc Chairman of the Board 138.1 K 331.6 %
2018 Lumos Pharma Inc - 33.6 K -84.8 %
2018 Lumos Pharma Inc Independent Director - -
2018 Milestone Pharmaceuticals Inc Director and Chairperson of the Board - -
2018 Xeris Biopharma Holdings Inc Chairman of the Board, President and Chief Executi - -
2017 Lumos Pharma Inc Independent Director 221.0 K -0.0 %
2017 Iterum Therapeutics Plc Chairman of the Board 32.0 K -
2017 Xeris Biopharma Holdings Inc Chairman of the Board, President and Chief Executi - -
2016 Lumos Pharma Inc Independent Director 221.1 K -31.1 %
2015 Lumos Pharma Inc Independent Director 321.0 K 5.8 %
2014 Lumos Pharma Inc Independent Director 303.4 K 82.3 %
2013 Lumos Pharma Inc Independent Director 166.5 K 15.8 %
2012 Lumos Pharma Inc Independent Director 143.7 K 194.8 %
2011 Lumos Pharma Inc Independent Director 48.7 K -
2010 Lumos Pharma Inc Independent Director - -